表紙
市場調査レポート

熱帯性痙性麻痺:世界の治験レビュー

Tropical Spastic Paraparesis Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 170869
出版日 ページ情報 英文 51 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.12円で換算しております。
Back to Top
熱帯性痙性麻痺:世界の治験レビュー Tropical Spastic Paraparesis Global Clinical Trials Review, H2, 2014
出版日: 2014年08月12日 ページ情報: 英文 51 Pages
概要

当レポートでは、熱帯性痙性麻痺に関する臨床研究の最新動向について分析し、疾患治療法の概要や、治験における主要国、G7諸国およびE7(新興7カ国)における治験数および被験者採用の状況、フェーズ(相)段階別の進行状況、有望なスポンサー、各企業研究機関での研究の進行状況、有望な薬剤の比較といった情報をまとめてお届けします。

目次

イントロダクション

  • 熱帯性痙性麻痺
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋の主要国における治験件数
    • 欧州の主要国における治験件数
    • 北米の主要国における治験件数
    • 中東およびアフリカにおける治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:中枢神経系の治験件数に対する熱帯性痙性麻痺の治験件数比率

G7諸国での治験件数:フェーズ(相)別

G7諸国での治験件数:進捗状況別

E7諸国(新興7カ国)での治験件数:中枢神経系の治験件数に対する熱帯性痙性麻痺の治験件数比率

E7諸国(新興7カ国)での治験件数:進捗状況別

フェーズ(相)別の治験件数

  • 進行中の治験:フェーズ(相)別

進捗状況別の治験件数

エンドポイント達成状況別の治験件数

未達成の治験件数

一定期間に採用された被験者

スポンサーの種類別治験件数

有望な薬剤

治験のプロファイル

  • 代表的な研究機関・病院の治験の概要
    • National Institute of Neurological Disorders and Stroke
    • Imperial College London
    • Hospital Universitrio Professor Edgard Santos
    • St. Marianna University School of Medicine
    • University of Sao Paulo
    • National Taiwan University Hospital
    • University of Oxford
    • National Cancer Institute
    • Massachusetts General Hospital

5つの代表的な治験のプロファイル

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

GlobalData's clinical trial report, "Tropical Spastic Paraparesis Global Clinical Trials Review, H2, 2014" provides data on the Tropical Spastic Paraparesis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tropical Spastic Paraparesis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tropical Spastic Paraparesis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Tropical Spastic Paraparesis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Tropical Spastic Paraparesis to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Tropical Spastic Paraparesis to Central Nervous System Clinical Trials
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Tropical Spastic Paraparesis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Drugs
    • Clinical Trial Overview of Top Institutes / Government
      • National Institute of Neurological Disorders and Stroke
      • Clinical Trial Overview of National Institute of Neurological Disorders and Stroke
      • Imperial College London
      • Clinical Trial Overview of Imperial College London
      • Hospital Universitrio Professor Edgard Santos
      • Clinical Trial Overview of Hospital Universitrio Professor Edgard Santos
      • St. Marianna University School of Medicine
      • Clinical Trial Overview of St. Marianna University School of Medicine
      • University of Sao Paulo
      • Clinical Trial Overview of University of Sao Paulo
      • National Taiwan University Hospital
      • Clinical Trial Overview of National Taiwan University Hospital
      • University of Oxford
      • Clinical Trial Overview of University of Oxford
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Massachusetts General Hospital
      • Clinical Trial Overview of Massachusetts General Hospital
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Tropical Spastic Paraparesis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Tropical Spastic Paraparesis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Tropical Spastic Paraparesis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Tropical Spastic Paraparesis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Tropical Spastic Paraparesis Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Tropical Spastic Paraparesis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Tropical Spastic Paraparesis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Tropical Spastic Paraparesis to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Tropical Spastic Paraparesis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Tropical Spastic Paraparesis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Tropical Spastic Paraparesis to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Tropical Spastic Paraparesis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Tropical Spastic Paraparesis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Tropical Spastic Paraparesis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Tropical Spastic Paraparesis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Tropical Spastic Paraparesis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Tropical Spastic Paraparesis Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Tropical Spastic Paraparesis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Tropical Spastic Paraparesis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Tropical Spastic Paraparesis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Tropical Spastic Paraparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014*
  • Tropical Spastic Paraparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2014*
  • Tropical Spastic Paraparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Universitrio Professor Edgard Santos, 2014*
  • Tropical Spastic Paraparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Marianna University School of Medicine, 2014*
  • Tropical Spastic Paraparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2014*
  • Tropical Spastic Paraparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014*
  • Tropical Spastic Paraparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014*
  • Tropical Spastic Paraparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Tropical Spastic Paraparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014*

List of Figures

  • Tropical Spastic Paraparesis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Tropical Spastic Paraparesis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Tropical Spastic Paraparesis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Tropical Spastic Paraparesis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Tropical Spastic Paraparesis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Tropical Spastic Paraparesis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Tropical Spastic Paraparesis to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Tropical Spastic Paraparesis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Tropical Spastic Paraparesis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Tropical Spastic Paraparesis to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Tropical Spastic Paraparesis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Tropical Spastic Paraparesis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Tropical Spastic Paraparesis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Tropical Spastic Paraparesis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Tropical Spastic Paraparesis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Tropical Spastic Paraparesis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Tropical Spastic Paraparesis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top